Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.150
+0.140 (4.65%)
Jan 17, 2025, 4:00 PM EST - Market closed
Neuphoria Therapeutics Statistics
Total Valuation
NEUP has a market cap or net worth of $11.07 billion. The enterprise value is $11.06 billion.
Market Cap | 11.07B |
Enterprise Value | 11.06B |
Important Dates
The next estimated earnings date is Thursday, February 13, 2025.
Earnings Date | Feb 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NEUP has 3.51 billion shares outstanding. The number of shares has increased by 41.23% in one year.
Current Share Class | 3.51B |
Shares Outstanding | 3.51B |
Shares Change (YoY) | +41.23% |
Shares Change (QoQ) | +48.77% |
Owned by Insiders (%) | 0.19% |
Owned by Institutions (%) | 6.68% |
Float | 3.51B |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | 3,865.20 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.30, with a Debt / Equity ratio of 0.01.
Current Ratio | 3.30 |
Quick Ratio | 3.21 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -55.39% and return on invested capital (ROIC) is -50.11%.
Return on Equity (ROE) | -55.39% |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | -50.11% |
Revenue Per Employee | n/a |
Profits Per Employee | -$451,016 |
Employee Count | 24 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -184,714 |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 36.35 |
Average Volume (20 Days) | 120,502 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -15.90M |
Pretax Income | n/a |
Net Income | -10.82M |
EBITDA | -15.45M |
EBIT | -15.90M |
Earnings Per Share (EPS) | -$0.01 |
Balance Sheet
The company has $8.08 million in cash and $219,350 in debt, giving a net cash position of $7.86 million or $0.00 per share.
Cash & Cash Equivalents | 8.08M |
Total Debt | 219,350 |
Net Cash | 7.86M |
Net Cash Per Share | $0.00 |
Equity (Book Value) | 17.07M |
Book Value Per Share | 0.01 |
Working Capital | 5.88M |
Cash Flow
Operating Cash Flow | -14.68M |
Capital Expenditures | n/a |
Free Cash Flow | -14.68M |
FCF Per Share | -$0.00 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NEUP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -41.23% |
Shareholder Yield | -41.23% |
Earnings Yield | -0.10% |
FCF Yield | -0.13% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |